Clinical trialNCT02281357CompletedPhase 3Interventional

Phase 3 Study to Evaluate the Efficacy & Safety of Tralokinumab in Adults & Adolescents With OCS Dependent Asthma

SponsorAstraZenecaEnrollment140Asthma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

William W Busse, M.D.
University of Wisconsin School of Medicine and Public Health, Department of Medicine, Allergy & Immunology
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

51 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium

Research Site
Brussels (Anderlecht), Belgium
Research Site
Ghent, Belgium
Research Site
Hasselt, Belgium
Research Site
Leuven, Belgium
Research Site
Woluwé-St-Lambert, Belgium

France

Research Site
Grenoble, France
Research Site
Lille, France
Research Site
Lyon, France
Research Site
Nantes, France
Research Site
Pessac, France

Germany

Research Site
Berlin, Germany
Research Site
Berlin, Germany
Research Site
Frankfurt, Germany
Research Site
Hamburg, Germany
Research Site
Hanover, Germany
Research Site
Mainz, Germany
Research Site
München, Germany
Research Site
München-Pasing, Germany

Netherlands

Research Site
Amsterdam, Netherlands
Research Site
Groningen, Netherlands
Research Site
Leeuwarden, Netherlands

Poland

Research Site
Bystra, Poland
Research Site
Krakow, Poland
Research Site
Krakow, Poland
Research Site
Lodz, Poland
Research Site
Lubin, Poland
Research Site
Ostrowiec Świętokrzyski, Poland
Research Site
Rzeszów, Poland
Research Site
Wroclaw, Poland
Research Site
Wroclaw, Poland

Ukraine

Research Site
Dnipro, Ukraine
Research Site
Kharkiv, Ukraine
Research Site
Kharkiv, Ukraine
Research Site
Kyiv, Ukraine
Research Site
Kyiv, Ukraine
Research Site
Vinnytsia, Ukraine

United States

Research Site
New Haven, Connecticut, United States
Research Site
Clearwater, Florida, United States
Research Site
St Louis, Missouri, United States
Research Site
Rochester, New York, United States

11 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 19 Feb 2015
Primary completion: 7 Sept 2017
Completion: 7 Sept 2017
Last update posted: 15 Mar 2019
Registered enrollment: 140
Registry id: NCT02281357

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.